Express Scripts Adds Three Biosimilars to Largest Formulary to Promote Competition and Advance Affordability, Choices for Patients
Read More
Despite Stressors of Pandemic, 60 Percent of Women Say Their Plans to Have Children Have Not Changed, New Evernorth Report Finds
Three out of four women that stopped fertility treatments during the pandemic have either restarted or plan to within a year. Nearly 20 percent of older millennials and younger GenX women are accelera...
Read MoreHow Accredo’s field nurses enable patients to receive complex therapies without leaving home
In addition to employing more than 800 specialty pharmacists who are just a phone call away, Accredo fields a team of about 600 nurses who care for patients in their homes.
Read MoreWhat impact will the Inflation Reduction Act have on health plans?
Plan sponsors should be aware of the effects the law will have on Medicare Part D over the coming years.
Read MoreBiosimilars 101
To help clients prepare for the wave of biosimilars on the horizon, we answer some basic questions about these potentially game-changing medications.
Read MoreEnhancing recruitment for local clinical drug trials
During the panel, experts discussed ways they have navigated patient recruitment challenges.
Read MoreEvernorth Continues Work to Reduce Costs and Improve Health With Expanded and Innovative Digital Health Formulary Platform
First-in-industry Digital Health Formulary is expanded to better enable people to find effective digital solutions that address their most pressing health care needs
Read MoreClinically Speaking: Gene Therapies: Million-Dollar Miracles
Gene therapies bring much-needed hope for treating rare conditions, but also concerns, especially around affordability. Learn about strategies plan sponsors can take to address these million-dollar me...
Read MoreThe power of drug optimization
As plan sponsors consider impactful ways to manage spend in 2024 and beyond, the power of drug optimization should not be overlooked.
Read More